To investigate the underlying mechanisms of Post-COVID Syndrome (PCS), particularly focusing on mitochondrial dysfunction and immune dysregulation, through an integrated multi-omics analysis.
Key Findings:
Sustained suppression of mitochondrial oxidative phosphorylation (OXPHOS) across species and tissues, indicating a critical bioenergetic impairment.
Activation of mitochondrial stress responses and enrichment of inflammatory pathways, suggesting a link to chronic immune activation.
Skeletal muscle showed the most pronounced mitochondrial repression, correlating with fatigue, highlighting the need for targeted interventions.
Persistent OXPHOS suppression in heart and kidney tissues, with prolonged inflammatory signaling in lung tissue, indicating multi-organ involvement.
Transcriptional profiles in the nervous system indicated region-specific mitochondrial repression, which may relate to cognitive symptoms.
Prolonged downregulation of OXPHOS-associated programs in peripheral blood mononuclear cells (PBMCs) and serum, suggesting systemic effects.
Interpretation:
The findings suggest that persistent mitochondrial dysfunction and immune dysregulation are key features of PCS, linking bioenergetic impairment with chronic immune activation, which may inform future therapeutic strategies.
Limitations:
Study primarily based on animal models and human cohorts, which may limit generalizability to broader populations.
Lack of FDA-approved treatments or validated biomarkers for PCS complicates clinical application, necessitating further research.
Conclusion:
The study provides a framework for understanding the mechanisms of PCS, emphasizing the need for further mechanistic and therapeutic investigations to address mitochondrial dysfunction and immune dysregulation.
